ARTICLE | Top Story
DNA reacquires European Nutropin rights
June 8, 2001 7:00 AM UTC
Genentech (DNA) will reacquire from Schwarz rights to its Nutropin AQ recombinant human growth hormone and Nutropin Depot sustained release formulation for treatment of growth hormone deficiencies in ...